Enlitic, Inc. (ASX:ENL)

Australia · Delayed Price · Currency is AUD

0.0060

-0.0010 (-14.29%)

Jul 29, 2026, 4:10 PM AEST

-80.65% (1Y)

Market Cap	5.83M -77.4%
Revenue (ttm)	5.69M +251.9%
Net Income	-20.05M
EPS	-0.03
Shares Out	833.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,711,892
Open	0.0060
Previous Close	0.0070
Day's Range	0.0060 - 0.0070
52-Week Range	0.0040 - 0.0450
Beta	-0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Enlitic

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from med... [Read more]

Industry Health Information Services

Sector Healthcare

Founded 2014

Country United States

Stock Exchange Australian Securities Exchange

Ticker Symbol ENL

Full Company Profile

Financial Performance

In 2025, Enlitic's revenue was $3.80 million, an increase of 251.87% compared to the previous year's $1.08 million. Losses were -$13.37 million, -12.23% less than in 2024.

Financial numbers in USD Financial Statements